Bethlehem, United States
Saladax Biomedical Inc., based in Bethlehem, PA, is at the forefront of the biotechnology and health care sectors. Established in 2004, this privately owned enterprise has carved a niche by developing, manufacturing, and marketing assays that swiftly determine therapeutic drug levels. Their solutions are invaluable for psychiatrists and oncologists who need immediate data to enhance patient care.
The company’s catchphrase, “Clozapine drug level results rapid enough to be of clinical benefit,” highlights their mission of speed and precision in clinical settings. Since 2007, Saladax's technology has been vital for both clinical laboratories and point-of-care contexts. Their partnerships with leading pharmaceutical firms further integrate their offerings into clinical trials and companion diagnostics.
Saladax last received a $100.00K grant investment on 22 June 2020 from Ben Franklin Technology Partners of Northeastern Pennsylvania, underscoring investor confidence in their innovative capabilities and market impact.
